Chemomab Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
/PRNewswire/ — Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative…